Nasus Pharma Ltd. (NSRX)

Nasus Pharma will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$10.00 - $12.00

Shares Offered

Unknown

Deal Size

Unknown

Nasus Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-1.53	-1.05
Share-Based Compensation	0.01	0.04
Other Operating Activities	0.86	-0.02
Operating Cash Flow	-0.67	-1.03
Debt Issued / Paid	1	1.06
Other Financing Activities	-0.23	-
Financing Cash Flow	0.77	1.06
Net Cash Flow	0.1	0.04
Free Cash Flow	-0.67	-1.03

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).